Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Catheters recalled due to defect—FDA highlights risk of stroke or brain damage
The recall was put in place after a hydrophilic coating was discovered on the inside of the devices. According to the FDA, patients treated with the catheters could face a number of significant risks.
IVC filter recalled due to injury risk
Customers are urged to stop using these devices right away.
FDA clears new-look robotic system from Stereotaxis
GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.
Interventional cardiology showing more interest in endovascular procedures
Sahil Parikh, MD, said it was clear at TCT 2025 that the specialty is getting more and more involved with endovascular procedures for stroke, pulmonary embolism and peripheral artery disease.
Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data
The new findings, presented during a late-breaking presentation, focused on 110 PAD patients treated with Shockwave Medical's Javelin Peripheral IVL Catheter.

Cardiac injury in COVID-19 patients associated with higher in-hospital mortality

Cardiac injury is common among patients hospitalized with COVID-19, according to new research out of Wuhan, China. The study, published in JAMA Cardiology, also found that cardiac injuries were associated with an increased risk of in-hospital mortality.

Abdominal stent graft solution from Endologix gains FDA approval

Endologix, an Irvine, California-based healthcare technology company, has received FDA approval for its new abdominal stent graft solution.

Risk of death from stroke drops 24%

The primary reason behind this change is believed to be significant improvements in how healthcare providers care for stroke patients.

FDA updates warnings for cigarette packaging, advertisements—compliance required by June 2021

The FDA has published new requirements for the health warnings featured on cigarette packages and in cigarette advertisements.

Music therapy improves stroke survivors’ dexterity, mood

Music therapy can be a helpful neurorehabilitation tool for acute stroke patients on the mend, according to research published in Topics in Stroke Rehabilitation.

Some CV drugs increase exposure, psychoactive effects of THC

A host of prescription drugs—including warfarin and other CV medications—may have potential drug interactions with the THC and cannabidiol in marijuana, according to an article published in the Canadian Medical Association Journal.

Less than ⅕ of US stroke patients have timely access to thrombectomy

Just under 20% of Americans have rapid access to endovascular thrombectomy for stroke, according to a study out of the University of Texas Health Science Center at Houston.

Blood flows differently through men’s, women’s hearts

Blood travels differently through women’s hearts than it does through men’s, research has found, suggesting cardiologists may benefit from tailoring their treatments to a specific sex.

Vascular & Endovascular

Catheters recalled due to defect—FDA highlights risk of stroke or brain damage

IVC filter recalled due to injury risk

FDA clears new-look robotic system from Stereotaxis

Interventional cardiology showing more interest in endovascular procedures

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data